Blues Plan Restricts Medicines Approved Via Accelerated Approval

Blues Plan Restricts Medicines Approved Via Accelerated Approval

Published On: 01/03/2025Tags: Agencies, Biopharma, Cell and Gene Therapy, Clinical Labs, Drug Reform/Pricing, Health Insurance, Marketplace, Medicaid, Medical Devices, Medicare, Medicare Advantage, Oncology, PBMs, Physicians, Post Acute Care, Value-Based Care